1 Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

2 Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

3 Subjects: “...Interferon beta-1b / therapeutic use...”

4 “... of glatiramer acetate, IFN beta-1a, and IFN beta-1b, in treating patients with clinically isolated syndrome (CIS...”

5 Subjects: “...beta-Lactamases / biosynthesis...”

6 Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

7 Subjects: “...Interleukin-1beta / antagonists & inhibitors...”

8 Subjects: “...Adrenergic beta-Antagonists...”

9 Subjects: “...Adrenergic beta-2 Receptor Agonists / therapeutic use...”

10 “...Carbapenems are beta-lactam antibiotics with a very broad spectrum of activity and act...”

11 “...Carbapenems are beta-lactam antibiotics with a very broad spectrum of activity and act...”

12 “... with otitis media unable to take beta-lactams remains unclear. This review aims to synthesize evidence...”

13 “... with otitis media unable to take beta-lactams remains unclear. This review aims to synthesize evidence...”

14 “... manner similar to other fixed-dose combination inhaled corticosteroid/long-acting beta-agonist inhalers...”

15 “... not adequately controlled with a maintenance combination of a long-acting beta2 agonist and a medium or high dose...”

16 “...Further comparisons were made against different interferon (IFN) beta-1 formulations (Avonex...”

17 “...Further comparisons were made against different interferon (IFN) beta-1 formulations (Avonex...”

18 “... and nocturia. Mirabegron is selective beta 3-adrenoceptor agonist available as a 25 mg and 50 mg extended...”

19 “... in adult patients inadequately controlled with a maintenance combination of a long-acting beta-2 agonist...”

20 “... and nocturia. Mirabegron is selective beta 3-adrenoceptor agonist available as a 25 mg and 50 mg extended...”